PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1663545
PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1663545
Mammography Systems Market size was valued at US 2,591.65 Million in 2024, expanding at a CAGR of 8.00% from 2025 to 2032.
Mammography systems are used to detect and screen for disorders related to the breast, including breast cancer. It is a device that examines diseases or tumours associated with the breast using low-energy X-rays. Physicians can identify and treat medical disorders with the use of a noninvasive medical test called an X-ray (radiograph). Using ionizing radiation doses, mammography machines produce images that are subsequently examined for anomalies. One kind of breast imaging can identify cancer early, when it is most curable before women notice any symptoms. Invasive breast cancer affects nearly one in eight women in the United States, according to Breastcancer.org. Approximately 2,550 men are anticipated to receive a breast cancer diagnosis, while approximately 266,120 women are forecast to have the disease. The need for worldwide mammography systems is rising as a result of the rise in breast cancer cases in both developed and developing nations.
Furthermore, the market for mammography systems is expected to grow rapidly in the upcoming years due to a number of factors, including rising government campaigns to raise awareness of early detection, research and development (R&D) in the diagnosis and treatment fields, technological advancements, favourable reimbursement scenarios in many countries, and an ageing population. Additionally, screening mammograms are crucial for identifying the early stages of breast cancer. The advancement of the industry is also being aided by growing awareness of the significance of early breast cancer detection.
Mammography Systems Market- Market Dynamics
Rising Prevalence of Cancer
The prevalence of breast cancer is rising worldwide, making it a serious public health concern. Breast cancer is still the most frequent cancer among women worldwide, with over 2.3 million new cases reported in 2020, according to the World Health Organization. Around 7.9 million women will get breast cancer in 2021, indicating an increase in the disease's frequency. Women over 40 are more likely to get breast cancer, and age is a major risk factor for the disease. Actually, 1 in 8 American women will get breast cancer at some point in their lives, according to the American Cancer Society. Moreover, In 2020, more than 685,000 women lost their lives to breast cancer, raising concerns about the disease's mortality rates. Mammography systems are vital instruments in the fight against breast cancer since early identification is crucial to improving the disease's prognosis. Women's need for early detection and treatment choices is driving the demand for mammography systems due to the rising incidence of breast cancer. Better breast cancer screening initiatives, like routine mammograms, are essential for identifying the disease early on when therapy is most successful. As healthcare providers work to fulfil the growing demand for breast cancer screening services, this trend is propelling the market for mammography systems.
Mammography Systems Market- Key Insights
As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 8.00% over the forecast period (2025-2032)
Based on product segmentation, the digital mammography systems were predicted to show maximum market share in the year 2024
Based on end use segmentation, hospitals were the leading segment in 2024
On the basis of region, North America was the leading revenue generator in 2024
The Global Mammography Systems Market is segmented on the basis of Modality, Product, End Use, and Region.
Based on modality, the market is divided into Portable and Non-Portable. In 2024, the global market is dominated by the non-portable category. Usually, these systems are permanent installations in medical facilities like hospitals and imaging centres. High image quality, cutting-edge features, and an extensive array of functionalities are provided by non-portable mammography systems for precise and thorough breast imaging. Their diagnostic skills are improved by the digital technology they frequently have, such as computer-aided detection (CAD) software and digital detectors. Because non-portable mammography systems are already widely used in healthcare facilities and because specific, high-performance imaging systems are preferred for breast cancer screening and diagnosis, they are the most often used.
On the basis of product, the market is segregated into Digital Mammography Systems and Analog Mammography Systems. In 2024, the market was dominated by the digital mammography systems category, given that, in comparison to other devices, it can offer higher image resolution and early cancer detection. Digital mammography makes it possible to put the needle more quickly and accurately, which speeds up the biopsy process and reduces discomfort. Additionally, its enhanced contrast resolution and image manipulation capabilities can guarantee more precise breast cancer identification. Throughout the projected period, the availability of advantageous healthcare reimbursement policies combined with these advantageous features will increase product demand. Advanced screening methods like tomosynthesis and 3D mammography, which produce more precise images of breast tissue and can detect tiny breast tumours, are also made possible by digital systems.
Mammography Systems Market- Geographical Insights
In 2024, North America held a dominant position in the global market for Mammography Systems. There are several reasons for this increase, such as the rising prevalence of breast cancer, the increased awareness of early diagnosis, and the accessibility of reimbursement. According to the American Disease Society, 30% (or 1 in 3) of all new female malignancies each year are breast cancers, making it the most frequent disease among women in the US. Being the biggest market for mammography systems, North America offers manufacturers a plethora of opportunities. But the landscape is also very competitive. In order for manufacturers to succeed in this market, their goods must satisfy the needs of both providers and patients.
However, throughout the projected period, the Asia-Pacific region is anticipated to see the fastest CAGR. There have been notable advancements in the region's healthcare infrastructure, rising healthcare spending, and increased awareness of breast cancer screening. In Asia Pacific, nations like China, India, Japan, and South Korea are leading the way in market expansion. Mammography systems are in high demand in these nations because of their sizable populations and rising rates of breast cancer. The implementation of structured screening programs and aggressive promotion of breast cancer awareness campaigns by governments and healthcare institutions are also propelling market expansion. Another issue is the introduction of international market participants into the region and the development of technology.
There are a number of significant participants in the fiercely competitive worldwide mammography systems market, such as Toshiba Corporation, General Electric Company, Fujifilm Holding Corporation, Metaltronica SPA, Planmeca OY, and others. The intense rivalry between a number of significant firms defines the competitive environment in the worldwide market. Through innovation, technological developments, strategic alliances, and geographic growth, these businesses aim to hold onto their market share and obtain a competitive advantage. With businesses aggressively spending in R&D to launch new goods and technology, the competitive landscape is ever-changing. Market participants frequently use partnerships, acquisitions, and strategic collaborations to increase their client bases, geographic reach, and product portfolios. For instance, in May 2022, Volpara Health presented new products for its integrated platform for individualized breast care at the SBI/ACR Breast Imaging Symposium 2022. Volpara offers AI-driven breast software solutions for cancer risk assessment, volumetric breast density measurements, and mammography quality and reporting.
Recent Development
October 2023: Mammomat B. Brilliant, a new mammography framework with wide-angle tomosynthesis, was introduced by Siemens Healthineers. This is the first mammography machine to use the Flying Focal Spot Technology Innovation. It was Siemens Healthineers' first device that combined the new detector, the newly developed Flying Focus Spot tube, the Premia computer-based intelligence reconstruction, and wide-angle tomosynthesis to improve image quality.
February 2023: The World Health Organization (WHO) announced the launch of a new global project on breast cancer with the goal of lowering mortality rates and enhancing treatment. By 2040, it hopes to prevent millions of cases of breast cancer. Three crucial health stages are highlighted by the recently launched project: early detection, prompt diagnosis, and thorough management of breast cancer.
October 2022: Google Health and the medical technology startup iCAD announced a collaboration to integrate AI technology into breast imaging products. This was the first commercialization deal for Google Health's AI models for mammography, and it made the technology usable in actual clinical settings.